Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07006428 · ClinicalTrials.gov registry record · NA
Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens
A NA study of Age Related Cataracts, sponsored by Argus Research Center.
- Recruiting
- Registry status
- NA
- Development phase
- 290
- Enrollment target
- 3
- Study locations
NCT07006428: Recruiting NA study of Age Related Cataracts, sponsored by Argus Research Center.
NCT07006428 is a NA study of Age Related Cataracts that is actively recruiting participants, run by Argus Research Center. The registered enrollment target is 290 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07006428, a NA study of Age Related Cataracts, is actively recruiting participants, sponsored by Argus Research Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a two-part, multi-center, investigator-initiated clinical study comparing visual outcomes and patient satisfaction in subjects receiving bilateral implantation of either the Clareon PanOptix intraocular lens (IOL) or a comparable multifocal IOL. The study includes a retrospective/prospective pilot phase and a prospective, randomized comparison phase.
Conditions Studied
Interventions
- DEVICE Clareon PanOptix or PanOptix Toric IOLs
- DEVICE Comparable multifocal IOL
Study Locations (3)
California
- Wolstan & Goldberg Eye Associates - Torrance
Florida
- Tyson Eye - Cape Coral
Georgia
- North Georgia Eye Associates - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2025-05-07 |
| Est. Completion | 2025-11 |
| Phase | NA |
What NCT07006428 shows while recruiting
NCT07006428 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Age Related Cataracts appearing as the primary indexed condition, and to 2 interventions - of which Clareon PanOptix or PanOptix Toric IOLs is the first listed.
NCT07006428 reports a single indexed study location in California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT07006428 about?
NCT07006428 is a clinical study titled "Visual Performance of Clareon PanOptix vs. a Comparable Multifocal Intraocular Lens". This is a two-part, multi-center, investigator-initiated clinical study comparing visual outcomes and patient satisfaction in subjects receiving bilateral implantation of either the Clareon PanOptix intraocular lens (IOL) or a comparable multifocal IOL. The study includes a retrospective/prospective...
What is the current status of trial NCT07006428?
This trial is currently recruiting. It is a NA study. The enrollment target is 290 participants. The study started on 2025-05-07. Estimated completion is 2025-11.
What conditions does trial NCT07006428 study?
This clinical trial studies the following conditions: Age Related Cataracts.
What interventions are being tested in trial NCT07006428?
The interventions under investigation include: Clareon PanOptix or PanOptix Toric IOLs (DEVICE), Comparable multifocal IOL (DEVICE).
Who is sponsoring clinical trial NCT07006428?
This trial is sponsored by Argus Research Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07006428 being conducted?
This trial has 3 study locations across California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07006428's enrollment target sits among peer trials
290 375th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI